DrugPatentWatch Database Preview

Dow Pharm Company Profile

DOW PHARM has sixteen approved drugs.

There are sixteen US patents protecting DOW PHARM drugs.

There are fifty-nine patent family members on DOW PHARM drugs in twenty-two countries and twenty-four supplementary protection certificates in twelve countries.

International Patents:	59
US Patents:	16
Tradenames:	14
Ingredients:	11
NDAs:	16
Patent Litigation for Dow Pharm:	See patent lawsuits for Dow Pharm

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014		RX	Yes	Yes	10,105,444	➤ Sign Up	Y			➤ Sign Up
Dow Pharm	AKNE-MYCIN	erythromycin	OINTMENT;TOPICAL	050584-001	Jan 10, 1985		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Dow Pharm	ACANYA	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050819-001	Oct 23, 2008	AB	RX	Yes	Yes	8,288,434	➤ Sign Up	Y			➤ Sign Up
Dow Pharm	DOW-ISONIAZID	isoniazid	TABLET;ORAL	080330-002	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Dow Pharm	CETACORT	hydrocortisone	LOTION;TOPICAL	080426-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ONEXTON	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050819-002	Nov 24, 2014	5,733,886	➤ Sign Up
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	5,670,547	➤ Sign Up
Dow Pharm	OXSORALEN-ULTRA	methoxsalen	CAPSULE;ORAL	019600-001	Oct 30, 1986	4,454,152	➤ Sign Up
Dow Pharm	ACANYA	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050819-001	Oct 23, 2008	5,733,886	➤ Sign Up
Dow Pharm	ACANYA	benzoyl peroxide; clindamycin phosphate	GEL;TOPICAL	050819-001	Oct 23, 2008	6,117,843	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	1.2%/2.5%	➤ Subscribe	2012-12-20
➤ Subscribe	Topical Solution	10%	➤ Subscribe	2018-06-06
➤ Subscribe	Gel	1.2%/3.75%	➤ Subscribe	2015-09-30

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1458369/01	Switzerland	➤ Sign Up	PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009
2008000041	Germany	➤ Sign Up	PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218
2008 00029	Denmark	➤ Sign Up	PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
C/GB10/012	United Kingdom	➤ Sign Up	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
2013025,C1304992	Lithuania	➤ Sign Up	PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.